6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione and Myocardial Infarction

6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bian, Z; Cui, H; Shen, W; Tian, D; Yang, D	1

Other Studies

1 other study(ies) available for 6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione and Myocardial Infarction

Article	Year
Nanoparticle-based electrochemiluminescence immunosensor with enhanced sensitivity for cardiac troponin I using N-(aminobutyl)-N-(ethylisoluminol)-functionalized gold nanoparticles as labels. Biosensors & bioelectronics, 2011, Sep-15, Volume: 27, Issue:1 Topics: Biomarkers; Biosensing Techniques; Fluorescent Antibody Technique; Gold; Humans; Luminescent Measurements; Luminol; Metal Nanoparticles; Myocardial Infarction; Sensitivity and Specificity; Troponin	2011

Article

Year

Nanoparticle-based electrochemiluminescence immunosensor with enhanced sensitivity for cardiac troponin I using N-(aminobutyl)-N-(ethylisoluminol)-functionalized gold nanoparticles as labels.

Biosensors & bioelectronics, 2011, Sep-15, Volume: 27, Issue:1

Topics: Biomarkers; Biosensing Techniques; Fluorescent Antibody Technique; Gold; Humans; Luminescent Measurements; Luminol; Metal Nanoparticles; Myocardial Infarction; Sensitivity and Specificity; Troponin

2011